🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy of ARALAST NP A1PI au...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-03-08
Trial ID
NCT04440488
Treatments Being Tested
The drug Alpha-1 Antitrypsin (AAT, Aralast NP) is being tested in this stud...
Status
Terminated
Location
RADY Children's Hospital (University of California, San Diego)
Start Date
2010-10
Trial ID
NCT01183468
Treatments Being Tested
Islet transplantation is a relatively new procedure used in people with dif...
Status
Completed
Location
University of Alberta
Start Date
2015-08
Trial ID
NCT02520076
Treatments Being Tested
The purpose of this study is to evaluate the effects of weekly augmentation...
Status
Completed
Location
Multiple Locations
Start Date
2006-10-27
Trial ID
NCT00396006
Treatments Being Tested
The purpose of this study is to determine if the drug Alpha-1 Antitrypsin (...
Status
Completed
Location
Barbara Davis Center for Childhood Diabetes
Start Date
2010-10
Trial ID
NCT01319331
Treatments Being Tested
Patients with severe chronic pancreatitis may be candidates to have their p...
Status
Completed
Location
University of Minnesota
Start Date
2016-12
Trial ID
NCT02713997
Treatments Being Tested
The purpose of this study is to conduct a pilot study to evaluate the safet...
Status
Terminated
Location
Phoenix Medical Research Institute, LLC
Start Date
2016-11-02
Trial ID
NCT02722304
Treatments Being Tested
Neuromyelitis Optica (NMO) is a rare, devastating demyelinating disease of ...
Status
Withdrawn
Location
Stanford University
Start Date
2014-03
Trial ID
NCT02087813
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy of RYMPHYSIA \[A...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-01-01
Trial ID
NCT05466747
Treatments Being Tested
This is a Randomized, Open-Label Study of the Efficacy and Safety of Aralas...
Status
Withdrawn
Location
Blessing Corporate Services, Inc
Start Date
2021-01
Trial ID
NCT04675086
Treatments Being Tested